Allocation concealment in randomised trials: Defending against deciphering

Lancet

Volumn 359, Issue 9306, 2002, Pages 614-618

  Schulz, Kenneth F ^a   Grimes, David A ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; HYPOTHESIS; PHARMACY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESEARCH; REVIEW;

EID: 0037116839     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07750-4     Document Type: Review

References (35)

1. Comparing like with like: Some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments
2. Generation of allocation sequences in randomised trials: Chance, not choice
3. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals
4. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
5. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
6. The landscape and lexicon of blinding in randomised trials
7. Subverting randomization in controlled trials
8. Statistical aspects of clinical trial design
9. Meta-analysis of clinical trials as a scientific discipline, I: Control of bias and comparison with large co-operative trials
10. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
11. Quality of randomised clinical trials affects estimates of intervention
12. Assessing quality of controlled trials
13. The CONSORT statement: Revised recommendations for improving the quality of reports or parallel-group randomised trials
14. Understanding controlled trials: Randomisation methods - Concealment
15. Unbiased research and the human spirit: The challenges of randomized controlled trials
16. Randomised trials, human nature, and reporting guidelines
17. Randomisation and baseline comparisons in clinical trials
18. Low-dose dopamine in patients with early renal dysfunction: A placebo- controlled randomised trial
19. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial
20. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
21. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: A randomised controlled trial
22. Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study
23. Effect of sibutramine on weight maintenance after weight loss: A randomised trial
24. Use of the world wide web in research: Randomization in a multicenter clinical trial of treatment for twin-twin transfusion syndrome
25. Technologies for automating randomized treatment assignment in clinical trials
26. How well are randomized controlled trials reported in the dermatology literature?
27. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis
28. Use of the CONSORT statement and quality of reports of randomized trials: A comparative before-and-after evaluation
29. Statistical properties of randomization in clinical trials
30. Comparability of randomised groups
31. Designs for experiments: Parallel comparisons of treatment